Posted by Michael Wonder on 11 Sep 2023
EMA publishes agenda for 11-14 September 2023 CHMP meeting
11 September 2023 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Latanoprost
- Lebrikizumab
- Dabrafenib mesylate
- Trastuzumab
- Quizartinib
- Palopegteriparatide
- Zilucoplan
- Zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
